Clinical Trial Update: Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a bispecific antibody to detect tumor cells in patients with colorectal cancer; the status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bispecific antibody (unnamed)

Snippet

Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology | Conditions: Colorectal Cancer | Phase 1 | Status: UNKNOWN